New Data Published In Nature Genetics Demonstrate That Tiny LNA-Based Compounds Developed By Santaris Pharma A/S Inhibit Entire Disease-Associated MicroRNA Families
HOERSHOLM, Denmark and SAN DIEGO, March 21, 2011 /PRNewswire/ -- A study published online in this week's Nature Genetics demonstrates that tiny Locked Nucleic Acid (LNA)-based compounds developed by…